Krypton

CHEMBL1233877 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

83.8 g/mol

LogP

—

Phase

4

A radioactive noble gas used in nuclear medicine lung ventilation studies, particularly for evaluating pulmonary function and detecting lung abnormalities. When inhaled, it distributes throughout the lungs, allowing scintigraphic imaging.

Berat Molekul

83,8000 g/mol

TPSA

0,00 Å²

Area Terapeutik

Age-Related Macular Degeneration

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

[Kr]

InChI

InChI=1S/Kr

Molecular Formula

Kr

HBD / HBA

- / -

Ikatan yang Dapat Dirotasi

0

Atom Berat

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A radioactive noble gas used in nuclear medicine lung ventilation studies, particularly for evaluating pulmonary function and detecting lung abnormalities. When inhaled, it distributes throughout the lungs, allowing scintigraphic imaging.

Yes, Krypton is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1233877. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5416. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Krypton di PillFYI

Struktur

Data Cepat

Rumus: Kr

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.